Radiomics to predict response to immunotherapy: an imminent reality?
Author:
Affiliation:
1. Gustave Roussy, Université Paris-Saclay, Department of Radiotherapy, F-94805 Villejuif, France
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Reference19 articles.
1. PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
2. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
3. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
4. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
5. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nouveaux outils en cancérologie thoracique;Revue des Maladies Respiratoires Actualités;2024-06
2. A review in radiomics: Making personalized medicine a reality via routine imaging;Medicinal Research Reviews;2021-07-26
3. Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors;NeuroMolecular Medicine;2021-07-23
4. The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up;Frontiers in Oncology;2021-05-05
5. Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer;Future Oncology;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3